Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Chemours stock

Learn how to easily invest in Chemours stock.

Chemours Co is a specialty chemicals business based in the US. Chemours shares (CC) are listed on the NYSE and all prices are listed in US Dollars. Chemours employs 6,400 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Chemours

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – CC – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

Chemours stock price (NYSE: CC)

Use our graph to track the performance of CC stocks over time.

Chemours shares at a glance

Information last updated 2022-07-01.
Latest market close$31.47
52-week range$22.41 - $44.95
50-day moving average $37.72
200-day moving average $32.80
Wall St. target price$45.70
PE ratio 7.1794
Dividend yield $1 (3.15%)
Earnings per share (TTM) $4.46

Buy Chemours shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 5 of 5
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
eToro
Stocks, ETFs, Cryptocurrency
$0
$10
$10
when you sign up and deposit $100
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, or TN.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.
SoFi Invest
Stocks, ETFs, Cryptocurrency
$0
$1
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
Tastyworks
Stocks, Options, ETFs, Cryptocurrency
$0
$0
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
Robinhood
Stocks, Options, ETFs, Cryptocurrency
$0
$0
Get a free stock
when you open a Robinhood account
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Axos Bank Self Directed Investing
Stocks
$0
$1,000
$150
when you open an account and deposit at least $1500.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Chemours stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Chemours price performance over time

Historical closes compared with the close of $31.47 from 2022-07-01

1 week (2022-06-28) -0.82%
1 month (2022-06-02) -29.33%
3 months (2022-04-05) -3.50%
6 months (2022-01-05) -10.60%
1 year (2021-07-02) -11.45%
2 years (2020-07-02) 100.83%
3 years (2019-07-05) 48.09%
5 years (2017-07-05) 39.3

Is Chemours stock undervalued or overvalued?

Valuing Chemours stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Chemours's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Chemours's P/E ratio

Chemours's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 7x. In other words, Chemours shares trade at around 7x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

Chemours's PEG ratio

Chemours's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.4075. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Chemours's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Chemours's EBITDA

Chemours's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $1.2 billion.

The EBITDA is a measure of a Chemours's overall financial performance and is widely used to measure a its profitability.

Chemours financials

Revenue TTM $6.7 billion
Operating margin TTM 13.05%
Gross profit TTM $1.4 billion
Return on assets TTM 7.41%
Return on equity TTM 73.9%
Profit margin 11.18%
Book value $7.43
Market capitalisation $5 billion

TTM: trailing 12 months

Chemours share dividends

21%

Dividend payout ratio: 21.1% of net profits

Recently Chemours has paid out, on average, around 21.1% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 3.15% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Chemours shareholders could enjoy a 3.15% return on their shares, in the form of dividend payments. In Chemours's case, that would currently equate to about $1 per share.

While Chemours's payout ratio might seem low, this can signify that Chemours is investing more in its future growth.

Chemours's most recent dividend payout was on 14 June 2022. The latest dividend was paid out to all shareholders who bought their shares by 12 May 2022 (the "ex-dividend date").

Chemours share price volatility

Over the last 12 months, Chemours's shares have ranged in value from as little as $22.4113 up to $44.947. A popular way to gauge a stock's volatility is its "beta".

CC.US volatility(beta: 1.79)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Chemours's is 1.7945. This would suggest that Chemours's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Chemours overview

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through four segments: Titanium Technologies, Thermal & Specialized Solutions, Advanced Performance Materials, and Chemical Solutions. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure and BaiMax brands for delivering whiteness, brightness, opacity, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging. The Thermal & Specialized Solutions segment offers of refrigerants, thermal management solutions, propellants, foam blowing agents, and specialty solvents. The Advanced Performance Materials segment products portfolio includes various industrial resins, specialty products, membranes, and coatings for consumer electronics, semiconductors, digital communications, transportation, energy, oil and gas, and medical, and others applications. The Chemical Solutions segment comprises a portfolio of industrial chemicals used as raw materials and catalysts for gold production, clean and disinfect, oil and gas, water treatment, electronics, and automotive applications. The company sells its products through direct and indirect channels, as well as through a network of resellers and distributors.

Frequently asked questions

What percentage of Chemours is owned by insiders or institutions?
Currently 1.037% of Chemours shares are held by insiders and 78.077% by institutions.
How many people work for Chemours?
Latest data suggests 6,400 work at Chemours.
When does the fiscal year end for Chemours?
Chemours's fiscal year ends in December.
Where is Chemours based?
Chemours's address is: 1007 Market Street, Wilmington, DE, United States, 19899
What is Chemours's ISIN number?
Chemours's international securities identification number is: US1638511089
What is Chemours's CUSIP number?
Chemours's Committee on Uniform Securities Identification Procedures number is: 163851108

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site